Drug
Arq 197
Arq 197: highest development phase Phase 2, developed by Kyowa Kirin. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Kyowa Kirin
Trials
| Drug | Phase | Indication |
|---|---|---|
| ARQ 197 NCT01580735 | Phase 2 | Non-small-cell Lung Cancer |
Latest
No recent events.
Follow Arq 197 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.